Journal of Hepato-Biliary-Pancreatic Surgery

, Volume 16, Issue 5, pp 668–674 | Cite as

Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas

  • Jin-Young Jang
  • Yoon-Chan Park
  • Yoon Sup Song
  • Seung Eun Lee
  • Dae Wook Hwang
  • Chang-Sup Lim
  • Hee Eun Lee
  • Woo Ho Kim
  • Sun-Whe KimEmail author
Original article



The purpose of this study was to document the biological changes during the progression of intraductal papillary mucinous neoplasm of the pancreas (IPMN) and to identify biological markers capable of differentiating benign and malignant IPMN.


Forty-one patients with IPMN who underwent resection between 1994 and 2003 were enrolled in this study. The paraffin-embedded tumors from 27 with benign IPMNs and from 14 with IPMCs were subjected to immunohistochemical staining and DNA extraction. Direct DNA sequencing analysis for K-ras mutation and immunohistochemical staining using 17 biological markers was performed.


K-ras mutations at codon 12 and 13 were detected in 13 of 37 (38.2%) of the IPMNs: in 5 of 24 (20.8%) of benign IPMNs, and in 8 of 13 (61.5%) of malignant IPMNs (p = 0.028). The expression of S100A4 and MUC2 were increased in malignant IPMNs. S100A4 was expressed in 2 (7.4%) of 27 benign IPMNs, and 6 (42.9%) of 14 malignant IPMNs (p = 0.007). MUC2 was expressed in 2 (7.4%) benign IPMNs, and in 9 (64.3%) malignant IPMNs (p < 0.001).


K-ras mutation and the expression of S100A4 and MUC2 (especially in intestinal subtype) were found to be related to malignancy in IPMN, and may be useful for the diagnosis and for assessing the biological behavior of IPMN.


Intraductal papillary mucinous tumor of pancreas K-ras mutation MUC Malignancy 



This work was supported by SK research fund of the Korean Society of Gastroenterology (2003) and by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (No. 800-20050679).


  1. 1.
    Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977–87.PubMedCrossRefGoogle Scholar
  2. 2.
    Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas. 2007;35:348–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Takaori K. Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg. 2007;14:217–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, et al. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Virchows Arch. 2002;441:437–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, et al. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol. 2002;197:632–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol. 2008;15:199–205.PubMedCrossRefGoogle Scholar
  7. 7.
    Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124–32.PubMedCrossRefGoogle Scholar
  8. 8.
    Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639–46.PubMedCrossRefGoogle Scholar
  10. 10.
    Yonezawa S, Horinouchi M, Osako M, et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol Int. 1999;49:45–54.PubMedCrossRefGoogle Scholar
  11. 11.
    Lüttges J, Zamboni G, Longnecker D, Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Klöppel G, Solcia E, Longnecker DS, et al. Histological typing of tumours of the exocrine pancreas, WHO International histological classification of tumours. 2nd ed. Tokyo: Springer; 1996.Google Scholar
  14. 14.
    Park JH, Kim IJ, Kang HC, Shin Y, Park HW, Jang SG, et al. Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization. Clin Chem. 2004;50:1688–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Z’graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernández-del Castillo C, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg. 1997;226:491–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kaino M, Kondoh S, Okita S, Hatano S, Shiraishi K, Kaino S, et al. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors. Pancreas. 1999;18:294–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Biankin AV, Biankin SA, Kench JG, Morey AL, Lee CS, Head DR, et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 2002;50:861–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Kondo H, Sugano K, Fukayama N, Hosokawa K, Ohkura H, Ohtsu A, et al. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer. 1997;79:900–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Schönleben F, Qiu W, Bruckman KC, Ciau NT, Li X, Lauerman MH, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett.. 2007;249:242–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425:357–67.PubMedCrossRefGoogle Scholar
  21. 21.
    Hoshi T, Imai M, Ogawa K. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol. 1994;55:84–91.PubMedCrossRefGoogle Scholar
  22. 22.
    Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y, et al. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807–17.PubMedCrossRefGoogle Scholar
  23. 23.
    Kobayashi N, Inamori M, Fujita K, Fujisawa T, Fujisawa N, Takahashi H, et al. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms. J Hepatobiliary Pancreat Surg. 2008;15:169–77.PubMedCrossRefGoogle Scholar
  24. 24.
    Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem. 2006;281:677–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, Miyazaki N, et al. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol Rep. 2006;16:457–63.PubMedGoogle Scholar
  26. 26.
    Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol. 2002;160:45–50.PubMedGoogle Scholar
  27. 27.
    Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004;164:903–14.PubMedGoogle Scholar
  28. 28.
    Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62–77.PubMedCrossRefGoogle Scholar
  29. 29.
    Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg. 2002;9:328–41.PubMedCrossRefGoogle Scholar
  30. 30.
    Yonezawa S, Taira M, Osako M, Kubo M, Tanaka S, Sakoda K, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319–22.PubMedCrossRefGoogle Scholar
  31. 31.
    Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol. 2002;197:201–10.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Jin-Young Jang
    • 1
  • Yoon-Chan Park
    • 2
  • Yoon Sup Song
    • 1
  • Seung Eun Lee
    • 1
  • Dae Wook Hwang
    • 1
  • Chang-Sup Lim
    • 1
  • Hee Eun Lee
    • 3
  • Woo Ho Kim
    • 3
  • Sun-Whe Kim
    • 1
    Email author
  1. 1.Department of SurgerySeoul National University College of MedicineSeoulSouth Korea
  2. 2.Department of SurgeryDankook University HospitalChungcheongnam-doSouth Korea
  3. 3.Department of PathologySeoul National University College of MedicineSeoulSouth Korea

Personalised recommendations